UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 186

Sortiert nach

Subcutaneous immunoglobulin replacement therapy with Hizentra®, the first 20% SCIG preparation: a Practical approach

Advances in therapy, 2011-07, Vol.28 (7), p.521-533

2011

Volltextzugriff (PDF)

Efficacy and tolerability of 16% subcutaneous immunoglobulin compared with 20% subcutaneous immunoglobulin in primary antibody deficiency

Clinical and experimental immunology, 2015-09, Vol.181 (3), p.441-450

2015

Volltextzugriff (PDF)

Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections

Pediatrics (Evanston), 2001-08, Vol.108 (2), p.230

2001

Volltextzugriff (PDF)

Natural history of neonatal herpes simplex virus infections in the acyclovir era

Pediatrics (Evanston), 2001-08, Vol.108 (2), p.223

2001

Volltextzugriff (PDF)

Financial Impact of Late Diagnosis of Severe Combined Immunodeficiency: Why It is Fiscally Sound for States to Invest in the Implementation of Newborn Screening

Journal of allergy and clinical immunology, 2012-02, Vol.129 (2), p.AB247-AB247

2012

Volltextzugriff (PDF)

Subcutaneous Hizentra® (20%) Is Better Tolerated And Shares Similar Efficacy Compared To Subcutaneous Vivaglobin® (16%)

Journal of allergy and clinical immunology, 2012-02, Vol.129 (2), p.AB15-AB15

2012

Volltextzugriff (PDF)

FOXP3 expression following bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning

Immunologic research, 2009-07, Vol.44 (1-3), p.179-184

2009

Volltextzugriff (PDF)

Clinical assessment of medication adherence among HIV-infected children: examination of the Treatment Interview Protocol (TIP)

AIDS care, 2004-04, Vol.16 (3), p.323-337

2004

Volltextzugriff (PDF)

(507) - Novel Pediatric Ex-Vivo Preservation System for Low-Weight Donor Hearts in a Porcine Model

The Journal of heart and lung transplantation, 2024-04, Vol.43 (4), p.S251-S252

2024

Volltextzugriff (PDF)

Elevation of Soluble CD14 levels Supports Chronic Innate Immune Activation in Subjects with CVID, XLA, and SLE Compared to Healthy Subjects

Journal of allergy and clinical immunology, 2011-02, Vol.127 (2), p.AB10-AB10

2011

Volltextzugriff (PDF)

A Novel Mutation CHS1 (LYST) Mutation: Osteomyelitis in a Child with Chediak-Higashi Syndrome

Journal of allergy and clinical immunology, 2010-02, Vol.125 (2), p.AB74-AB74

2010

Volltextzugriff (PDF)

CD21-/low B Cells Are Increased in Both Common Variable Immune Deficiency (CVID) and Specific Antibody Deficiency(SAD)

Journal of allergy and clinical immunology, 2011, Vol.127 (2), p.AB135-AB135

2011

Volltextzugriff (PDF)

TRANSIENT LOSS OF PERIPHERAL B-CELLS IN A PATIENT WITH CONGENITAL ATHYMIA AND OMENN'S SYNDROME

Annals of allergy, asthma, & immunology, 2023-11, Vol.131 (5), p.S160-S160

2023

Volltextzugriff (PDF)

Abacavir Pharmacokinetics During Chronic Therapy in HIV-1-Infected Adolescents and Young Adults

Clinical pharmacology and therapeutics, 2009-04, Vol.85 (4), p.394-401

2009

Volltextzugriff (PDF)

Enteral glutamine supplementation for very low birth weight infants decreases morbidity

The Journal of pediatrics, 1997-11, Vol.131 (5), p.691-699

1997

Volltextzugriff (PDF)

Envelope V3 amino acid sequence predicts HIV-1 phenotype (co-receptor usage and tropism for macrophages)

AIDS (London), 2000-12, Vol.14 (18), p.2937-2939

2000

Volltextzugriff (PDF)

Evidence of macrophage activation in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAs)

Journal of allergy and clinical immunology, 2011-02, Vol.127 (2), p.AB231-AB231

2011

Volltextzugriff (PDF)

(209) Moving Toward Uniform Criteria for Adverse Event Definitions Across Mechanical Circulatory Support

The Journal of heart and lung transplantation, 2023-04, Vol.42 (4), p.S103-S103

2023

Volltextzugriff (PDF)

Varicella zoster as a manifestation of immune restoration disease in HIV-infected children

Journal of allergy and clinical immunology, 2004-04, Vol.113 (4), p.742-746

2004

Volltextzugriff (PDF)

Expression of CCR5 Increases during Monocyte Differentiation and Directly Mediates Macrophage Susceptibility to Infection by Human Immunodeficiency Virus Type 1

Journal of Virology, 1998-06, Vol.72 (6), p.4962-4969

1998

Volltextzugriff (PDF)

Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy

AIDS (London), 2010-06, Vol.24 (9), p.1281-1290

2010

Volltextzugriff (PDF)

Lyngbyatoxin A, A Cyanobacteria Dervived Aquatic Toxin, Induces Expression Of Pro-inflammatory Cytokines Including Il-4 And Il-5 By Human PBMC

Journal of allergy and clinical immunology, 2010-02, Vol.125 (2), p.AB81-AB81

2010

Volltextzugriff (PDF)

Immunoreconstitution after ritonavir therapy in children with human immunodeficiency virus infection involves multiple lymphocyte lineages

The Journal of pediatrics, 1999-05, Vol.134 (5), p.597-606

1999

Volltextzugriff (PDF)

Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection: a case report

Transplantation, 2002-03, Vol.73 (6), p.907

2002

Volltextzugriff (PDF)

CD4+ memory T cells are the predominant population of HIV-1-infected lymphocytes in neonates and children

AIDS (London), 1996-11, Vol.10 (13), p.1477-1484

1996

Volltextzugriff (PDF)

1 – 25 von 186

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(168)
Mit Volltextzugriff
(158)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(186)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Subcutaneous immunoglobulin replacement therapy with Hizentra®, the first 20% SCIG preparation: a Practical approach

Efficacy and tolerability of 16% subcutaneous immunoglobulin compared with 20% subcutaneous immunoglobulin in primary antibody deficiency

Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections

Natural history of neonatal herpes simplex virus infections in the acyclovir era

Financial Impact of Late Diagnosis of Severe Combined Immunodeficiency: Why It is Fiscally Sound for States to Invest in the Implementation of Newborn Screening

Subcutaneous Hizentra® (20%) Is Better Tolerated And Shares Similar Efficacy Compared To Subcutaneous Vivaglobin® (16%)

FOXP3 expression following bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning

Clinical assessment of medication adherence among HIV-infected children: examination of the Treatment Interview Protocol (TIP)

(507) - Novel Pediatric Ex-Vivo Preservation System for Low-Weight Donor Hearts in a Porcine Model

Elevation of Soluble CD14 levels Supports Chronic Innate Immune Activation in Subjects with CVID, XLA, and SLE Compared to Healthy Subjects

A Novel Mutation CHS1 (LYST) Mutation: Osteomyelitis in a Child with Chediak-Higashi Syndrome

CD21-/low B Cells Are Increased in Both Common Variable Immune Deficiency (CVID) and Specific Antibody Deficiency(SAD)

TRANSIENT LOSS OF PERIPHERAL B-CELLS IN A PATIENT WITH CONGENITAL ATHYMIA AND OMENN'S SYNDROME

Abacavir Pharmacokinetics During Chronic Therapy in HIV-1-Infected Adolescents and Young Adults

Enteral glutamine supplementation for very low birth weight infants decreases morbidity

Envelope V3 amino acid sequence predicts HIV-1 phenotype (co-receptor usage and tropism for macrophages)

Evidence of macrophage activation in Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAs)

(209) Moving Toward Uniform Criteria for Adverse Event Definitions Across Mechanical Circulatory Support

Varicella zoster as a manifestation of immune restoration disease in HIV-infected children

Expression of CCR5 Increases during Monocyte Differentiation and Directly Mediates Macrophage Susceptibility to Infection by Human Immunodeficiency Virus Type 1

Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy

Lyngbyatoxin A, A Cyanobacteria Dervived Aquatic Toxin, Induces Expression Of Pro-inflammatory Cytokines Including Il-4 And Il-5 By Human PBMC

Immunoreconstitution after ritonavir therapy in children with human immunodeficiency virus infection involves multiple lymphocyte lineages

Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection: a case report

CD4+ memory T cells are the predominant population of HIV-1-infected lymphocytes in neonates and children

Suchergebnisse filtern